Search Results 481-490 of 24239 for In situ

1. E-Mindfulness Approaches For Living After Breast Cancer - Mayo Clinic

   ... in situ cervical cancer without chemotherapy treatment would be eligible. * Currently pregnant or planning to become pregnant in the near future.

2. Student Life - Phoenix/Scottsdale, Arizona - Campus and Community - Mayo Clinic College of Medicine and Science

   ... in state-of-the-art environments. The Multidisciplinary Simulation Center offers courses, in-situ trainings, individual sessions, research studies, and ...

3. Breast cancer - Doctors and departments - Mayo Clinic

   ... in the United States, with campuses in Arizona, Florida and Minnesota. ... Roseberry, M.D.. Areas of focus: Ductal carcinoma in situ, Lobular carcinoma in situ ...

4. Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study - Mayo Clinic

   * Carcinoma in situ of the cervix * Carcinoma in situ of the breast * Incidental histological findings of prostate cancer such as T1a or T1b using the Tumor ...

5. Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in ... in situ cancer of the cervix). Patient is enrolled in a blinded clinical ...

6. A Phase 2/3 Study To Investigate The Safety And Efficacy Of Brepocitinib In Adults With Lichen Planopilaris (ALPINE) - Mayo Clinic

   Basal cell carcinoma, squamous cell carcinoma, ductal carcinoma in situ of the breast, carcinoma in situ of the uterine cervix, or thyroid carcinoma. Severe ...

7. Breast cancer - Doctors and departments - Mayo Clinic

   ... in the United States, with campuses in Arizona, Florida and Minnesota. ... Roseberry, M.D.. Areas of focus: Ductal carcinoma in situ, Lobular carcinoma in situ ...

8. A Study to Evaluate MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   History of malignancy < 5 years prior to signing the informed consent, except for adequately treated basal cell or squamous cell skin cancer or in situ cervical ...

9. A Multi-Center Study Evaluating KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia - Mayo Clinic

   History of malignancy other than non-melanoma skin cancer or carcinoma in situ (e.g. cervix, bladder, breast) unless disease free for at least 3 years ...

10. Study of ASTX727 vs IV Decitabine in MDS and CMML - Mayo Clinic

    Prior malignancy, except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, prostate cancer or breast cancer under ...